Moderna
MRNA
#1416
Rank
โ‚น1.063 T
Marketcap
โ‚น2,751
Share price
2.03%
Change (1 day)
-70.16%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2024 (TTM): โ‚น269.65 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is โ‚น274.01 Billion. a decrease over the revenue in the year 2023 that were of โ‚น562.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น274.43 B-51.19%
2023 โ‚น562.26 B-64%
2022 โ‚น1.561 T18.32%
2021 โ‚น1.320 T6478.8%
2020 โ‚น20.06 B485.79%
2019 โ‚น3.42 B-60.1%
2018 โ‚น8.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.496 T 1,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.85 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น192.57 B-29.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.430 T 1,516.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น0.21 B-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.608 T 2,676.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.51 B-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA